As for writing (Feb 2022), rates of COVID-19 remain high worldwide.
Although the pandemic has been ongoing for over 2 years and although the omnicron variant seems to be less severe and although we have vaccines, COVID-19 infection remains a threat...especially to vulnerable individuals such as the elderly and those with underlying conditions.
In addition, long COVID can affect anyone - even if the actual COVID infection is mild and even if the individual is young, healthy, fit and active with no underlying condition(s).
It is important to note that the research reports that:
earlier supplementation with these targeted nutrients had the most benefit
This should not be surprising! Imaging having a heart attack or even a broken leg and waiting a week or 2 before getting medical attention!
- Ling SF, Broad E, Murphy R, Pappachan JM, Pardesi-Newton S, Kong MF, Jude EB. High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study. 2020 Dec 11;12(12):3799. doi: 10.3390/nu12123799.
- Loucera C, Peña-Chilet M, Esteban-Medina M, Muñoyerro-Muñiz D, Villegas R, Lopez-Miranda J, Rodriguez-Baño J, Túnez I, Bouillon R, Dopazo J, Quesada Gomez JM. Real world evidence of calcifediol or vitamin D prescription and mortality rate of COVID-19 in a retrospective cohort of hospitalized Andalusian patients. Sci Rep. 2021 Dec 3;11(1):23380.
- Lakkireddy M, Gadiga SG, Malathi RD, Karra ML, Raju ISSVPM, Ragini, Chinapaka S, Baba KSSS, Kandakatla M. Impact of daily high dose oral vitamin D therapy on the inflammatory markers in patients with COVID 19 disease. Sci Rep. 2021 May 20;11(1):10641. doi: 10.1038/s41598-021-90189-4.
- --> 5 days
- Elamir YM, Amir H, Lim S, Rana YP, Lopez CG, Feliciano NV, Omar A, Grist WP, Via MA. A randomized pilot study using calcitriol in hospitalized COVID-19 patients. 2021 Sep 8;154:116175. doi: 10.1016/j.bone.2021.116175. Online ahead of print.
- Chopra A, Srikanth N, Patwardhan B; AYUSH CCRAS Research Group. Withania somnifera as a safer option to hydroxychloroquine in the chemoprophylaxis of COVID-19: Results of interim analysis. Complement Ther Med. 2021 Nov;62:102768.
Annweiler et al. reported that the hospitalised frail elderly patients who had regularly taken bolus vitamin D supplementation before hospitalisation with COVID-19 had significantly better survival rates than others
We have a produced a series of articles titled 'Best supplements for COVID-19: the scientific research regarding:
